海南海药 (000566)
HAINAN HAIYAO CO.,LTD
K-Line Chart
No K-line data
Company NameHainan Haiyao Co., Ltd.
Listing Date1994-05-25
Issue Price5.8Yuan
Registered Capital129736.512610K Yuan
Legal RepresentativeWang Jianping
Registered AddressNo. 192 Nanhai Avenue, Xiuying District, Haikou City, Hainan Province
IndustryChemical Pharmaceuticals
Main BusinessChinese and Western patent medicines, fine chemical products, chemical raw materials, health products, and import and export trade supporting the pharmaceutical industry.
Company ProfileHainan Haiyao Co., Ltd. (formerly Haikou Pharmaceutical Factory) was founded in 1965, completed its shareholding system reform in 1992, and was listed on the Shenzhen Stock Exchange in 1994 (Stock Code: 000566). Its product line structure is reasonable and dosage forms are diverse. Among over 130 product specifications, well-known products include: the traditional Chinese medicine series represented by Fengliao Changweikang Granules, the anti-tumor drug series represented by Taxol (Paclitaxel Injection), a relatively complete antibiotic series represented by Cefoxitin Sodium for Injection, Ceftizoxime Sodium, Meropenem, Aztreonam, Cefaclor, etc., and the vitamin series represented by Vitamin C for Injection.
Stock Details
1. Key Indicators
- Total Shares(W): 129736.51
- Circulating A-Shares(W): 129673.56
- Earnings Per Share(RMB): -0.1868
- Net Assets Per Share(RMB): 0.2146
- Operating Revenue(W RMB): 63968.38
- Total Profit(W RMB): -25898.90
- Net Profit Attributable to Parent(W RMB): -24230.73
- Net Profit Growth Rate(%): 17.91
- Weighted Return on Equity(%): -60.1700
- Operating Cash Flow Per Share(RMB): 0.0200
- Undistributed Profit Per Share(RMB): -2.9841
- Capital Reserve Per Share(RMB): 2.1537
2. Main Business
The main business covers:
- Drug research, development, production, and sales
3. Company Basic Information
- Company Name: Hainan Haiyao Co., Ltd.
- Listing Date: 1994-05-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 192 Nanhai Avenue, Xiuying District, Haikou City, Hainan Province
- Website: www.haiyao.com.cn
- Company Profile：The company's predecessor was Haikou Pharmaceutical Factory. In August 1992, it began restructuring into a joint-stock company, converting the factory's net assets into 31.9926 million state shares, privately placing 28.0074 million corporate shares and 15 million employee shares. After its initial public offering in January 1994, the total shares at listing were 100 million. The 14.9028 million employee shares were listed for trading on December 29, 1994.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hainan Huatong Industrial Co., Ltd. | General Legal Person | 29698.99 | 25.47 |
| 2 | Yunnan International Trust Co., Ltd. - Juli No. 36 Single Fund Trust | General Legal Person | 6829.55 | 5.86 |
| 3 | Jinyuan Shun'an Fund - Agricultural Bank of China - Hangzhou Tongwu Investment Management Partnership (Limited Partnership) | Asset Management Plan | 1308.25 | 1.12 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 664.64 | 0.57 |
| 5 | <值> | <值> | <值> | <值> |
| 6 | <值> | <值> | <值> | <值> |
| 7 | <值> | <值> | <值> | <值> |
| 8 | <值> | <值> | <值> | <值> |
| 9 | <值> | <值> | <值> | <值> |
| 10 | <值> | <值> | <值> | <值> |
5. Concept Sectors
- Venture Capital
- Biological Vaccine
- Hainan Free Trade Port
- Private Hospital
- Immunotherapy
- Smart Healthcare
- Generic Drugs
- Mask Protection
- Medical Aesthetics
- Hepatitis Concept
- Innovative Drugs
- Margin Trading
- High Price-to-Book Ratio
- Loss-making Stocks
- Consecutive Losses
- Equity Transfer
- High Debt Ratio
- Recently Unlocked Shares
- Low Safety Score
- CSI Central Enterprises
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information